Drug Trial Radar · NCT06644417
Clinical Study of TQA3605 Tablets Combined With Nucleoside (Acid) Analogs (NAs) Drugs Compared With NAs Drugs in the Treatment of Chronic Hepatitis B Virus (HBV) Infection
Last checked: Nov 19, 2026Latest source record: Jan 26, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
122
Actual
Start
Nov 14, 2024
Primary completion
Aug 25, 2025
Study completion Dec 10, 2025
Sponsor
- Lead sponsor
- Chia Tai Tianqing Pharmaceutical Group Co., Ltd.Industry
- Sponsor type
- Industry
- First posted
- Oct 16, 2024
Design
- Study type
- Interventional
- Phase
- Phase 2
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Quadruple (participant, care provider, investigator, outcomes assessor)
- Primary purpose
- Treatment
- FDA-regulated drug
- No
- Who can join
- All sexes, from 18 years, up to 65 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This study is a phase II multicenter, randomized, double-blind, placebo controlled study designed to evaluate the efficacy and safety in LLV subjects and demonstrate that TQA3605 tablets combined with oral NAs drugs can improve the efficacy and safety of LLV subjects compared with oral NAs drug.
Conditions
- HBV Infection With LLV
Interventions
TQA3605 tablets plus NAsDrug
TQA3605 tablets is core protein regulator
TQA3605 Placebo plus NAsDrug
Placebo without drug substance
Primary outcomes
What the sponsor says the trial is designed to measure.
- HBV DNA (Hepatitis B virus Deoxyribonucleic Acid)Time frame: 24 weeks
Locations
19 sites in 1 country. Site status is shown where the registry gives one.
Beijing Ditan Hospital Capital Medical University
Beijing, Beijing Municipality, China
Beijing Youan Hospital, Capital Medical Universitybeijing Institute of Hepatology
Beijing, Beijing Municipality, China
Meng Chao Hepatobiliary Hospital of Fujian Medical University
Fuzhou, Fujian, China
Peking University Shenzhen Hospital
Shenzhen, Guangdong, China
Guizhou Provincial People's Hospital
Guiyang, Guizhou, China
Zunyi Medical University Affiliated Hospital
Zunyi, Guizhou, China
Zhengzhou No.6 peoples Hospital
Zhengzhou, Henan, China
The Second XIANGYA Hospital Of Central South University
Changsha, Hunan, China
Yueyang Central Hospital
Yueyang, Hunan, China
Jiangsu Provincial People's Hospital
Nanjing, Jiangsu, China
The Fifth People's Hospital of Suzhou
Suzhou, Jiangsu, China
The First Affiliated Hospital of Nanchang University
Nanchang, Jiangxi, China
The sixth people's Hospital Of Shenyang
Shenyang, Liaoning, China
Shandong Public Health Clinical Center
Jinan, Shandong, China
Ruijin Hospital Affiliated to Shanghai Jiaotong University School of Medicine
Shanghai, Shanghai Municipality, China
Shanghai Tongren Hospital
Shanghai, Shanghai Municipality, China
The First Affiliated Hospital of Xi'an Jiao Tong University
Xi’an, Shanxi, China
The First Affiliated Hospital Zhejiang University School Of Medicine
Hangzhou, Zhejiang, China
Lishui People's Hospital
Lishui, Zhejiang, China
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.